BFPW
BSX icon

BOK Financial Private Wealth’s Boston Scientific BSX Stock Holding History

BOK Financial Private Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.9K Sell
888
-2,932
-77% -$159K ﹤0.01% 306
2026
Q1 		$240K Sell
3,820
-394
-9% -$31.5K 0.01% 168
2025
Q4 		$402K Buy
4,214
+246
+6% +$24.1K 0.02% 141
2025
Q3 		$387K Buy
3,968
+3,599
+975% +$373K 0.02% 137
2025
Q2 		$39.6K Hold
369
– – ﹤0.01% 262
2025
Q1 		$37.2K Sell
369
-28
-7% -$2.82K ﹤0.01% 284
2024
Q4 		$35.5K Buy
397
+28
+8% +$2.46K ﹤0.01% 290
2024
Q3 		$30.9K Hold
369
– – ﹤0.01% 309
2024
Q2 		$28.4K Hold
369
– – ﹤0.01% 315
2024
Q1 		$25.3K Sell
369
-369
-50% -$23.7K ﹤0.01% 314
2023
Q4 		$42.7K Hold
738
– – ﹤0.01% 261
2023
Q3 		$39K Buy
+738
New +$38.7K ﹤0.01% 246
2022
Q2 		– Sell
-5,885
Closed -$261K – 379
2022
Q1 		$261K Buy
+5,885
New +$255K 0.02% 257

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BOK Financial Private Wealth's BSX Position: Q2 2026 in Review

BOK Financial Private Wealth reduced its Boston Scientific (BSX) stake by 77% in Q2 2026, selling an estimated $159K and leaving 888 shares worth $37.9K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

BOK Financial Private Wealth first reported a position in BSX in Q1 2022 and has held it in 13 quarters since. The position peaked at $402K in Q4 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • BOK Financial Private Wealth held 888 shares of Boston Scientific worth $37.9K as of Q2 2026.
  • BOK Financial Private Wealth sold 2,932 Boston Scientific shares in Q2 2026, an estimated $159K.
  • Boston Scientific made up ﹤0.01% of BOK Financial Private Wealth's portfolio in Q2 2026, its #306 holding.
  • BOK Financial Private Wealth first reported a position in Boston Scientific in Q1 2022 and has held it in 13 quarters since.
  • BOK Financial Private Wealth's Boston Scientific position peaked at $402K in Q4 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on BOK Financial Private Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.